menu
    • menu

    Company profile for VitriVax

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VitriVax is a formulation technology company engineering innovative solutions to maximize global accessibility and utility of human and animal vaccines – vaccines that save lives and protect our world from preventable diseases. The company offers a proprietary Atomic Layering Thermostable Antigen and Adjuvant (ALTA) technology platform to enable thermostable, single-shot vaccines across a broad range of indications while mai...
    VitriVax is a formulation technology company engineering innovative solutions to maximize global accessibility and utility of human and animal vaccines – vaccines that save lives and protect our world from preventable diseases. The company offers a proprietary Atomic Layering Thermostable Antigen and Adjuvant (ALTA) technology platform to enable thermostable, single-shot vaccines across a broad range of indications while maintaining or potentially even enhancing the immune response of vaccines, enabling users to incorporate prime doses and additional booster doses in a single-shot administration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VitriVaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3415 Colorado Avenue, Boulder, CO 80303
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vitrivaxbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vitrivax/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VitriVax Joins BioMed Realty At Flatiron Park Boulder
    VitriVax Joins BioMed Realty At Flatiron Park Boulder

    24 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-24/next-generation-vaccine-platform-technology-company-vitrivax-joins-biomed-realty-s-roster-of-innovat

    PHARMIWEB
    24 Mar 2026
    Share Share
    Vitrivax Secures $17.25M For Vaccine Formulation Advancement
    Vitrivax Secures $17.25M For Vaccine Formulation Advancement

    22 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251022627536/en/VitriVax-Raises-%2417.25-Million-Series-B-Financing-to-Advance-Vaccine-Formulation-Platform

    BUSINESSWIRE
    22 Oct 2025
    Share Share
    Vitrivax Secures $9.9M Grant For Clinical Manufacturing Expansion
    Vitrivax Secures $9.9M Grant For Clinical Manufacturing Expansion

    14 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251014489846/en/VitriVax-Awarded-%249.9M-Grant-to-Enable-Scaling-up-of-Clinical-Manufacturing

    BUSINESSWIRE
    14 Oct 2025
    Share Share
    VitriVax Gets CEPI Grant to Develop Single-Dose Rabies Vaccine
    VitriVax Gets CEPI Grant to Develop Single-Dose Rabies Vaccine

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428959225/en/VitriVax-Receives-Grant-From-the-Coalition-for-Epidemic-Preparedness-Innovations-CEPI-to-Leverage-ALTA-Technology-for-Single-Dose-Rabies-Vaccine

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    VitriVax Awarded $3.6M Grant for Polio Vaccine Development
    VitriVax Awarded $3.6M Grant for Polio Vaccine Development

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241204004876/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    VitriVax Receives $5M Grant for Vaccine Development
    VitriVax Receives $5M Grant for Vaccine Development

    06 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231206522400/en

    BUSINESSWIRE
    06 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search